Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

Número de PMA: P070027 · 2017-02-01

SolicitanteMedtronic Vascular
Fecha de decisión2017-02-01
Número PMAP070027
Código de productoMIH
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorCV

Resumen del dispositivo

SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT is the device name listed in this FDA 510(k) record. The listed applicant is Medtronic Vascular. It received FDA 510(k) clearance on 2017-02-01. The device is classified under product code MIH. It was reviewed by the CV advisory panel.

Preguntas frecuentes

What is the SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT?

SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT is a medical device that received FDA 510(k) clearance on 2017-02-01. The listed applicant is Medtronic Vascular.

When did SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT receive FDA 510(k) clearance?

The clearance date for SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT can be found in the official FDA records.

Who is the listed applicant for SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT?

The FDA 510(k) record lists Medtronic Vascular as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT?

The FDA product code for SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT is MIH.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑